Wayne Winegarden
Business & Economics
Protect Patients By Repealing the Medical Device Tax
You don’t make health care more affordable by increasing its cost. Yet that is precisely what the currently suspended medical device tax threatens unless Congress permanently repeals it. Although permanent repeal failed in the last Congress, Senators Pat Toomey (R-PA) and Amy Klobuchar (D-MN) have introduced the Protect Medical Innovation Act, ...
Business & Economics
Gutting patents will stall medicine progress
Congress could soon vote on legislation that would gut America’s intellectual property laws. The bill isn’t just bad news for big pharmaceutical companies that hold lucrative patents. It’s terrible news for patients — medical research spending would dry up without strong patent protections. Americans could lose out on cures for ...
Business & Economics
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Business & Economics
Wayne Winegarden Discusses 15% Solution on Lars Larson Show
Listen to Dr. Wayne Winegarden, PRI Senior Fellow in Business and Economics as he joins Lars Larson to discuss his latest report detailing how we reach the “15 Percent Solution”, or the optimal level of federal spending to maximize economic growth and cut the national debt. The interview begins at ...
Business & Economics
Facing $22 Trillion National Debt, New PRI Report Shows How “15 Percent Solution” Can Cut Debt, Grow Economy
On the heels of the news that the national debt has surpassed $22 trillion, the Pacific Research Institute today recommended reforms to bring spending under control, reduce the national debt and maximize economic growth in the latest report in its Beyond the New Normal series. “Just last week, as we learned ...
Business & Economics
Public Pension Funds’ Sole Responsibility Is To Secure The Retirement Of Public Sector Workers
State and local public pension funds are trillions of dollars in debt. Without fully accounting for the risks, state public pension funds have $1.4 trillion in unfunded liabilities (e.g. debt) according to the Pew Center’s latest estimates. Even more troubling, this debt is still growing. The sole priority of a public pension ...
Business & Economics
Fostering Transparency In The Pharmaceutical Market
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
Business & Economics
Medicare price controls would harm patients and workers
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, the ...
Blog
Medical Economic Studies Should Come with a Warning Label
The old joke about the drunk and the policeman is apropos for far too many pharmaceutical studies. Typically, the joke goes something like the following: A policeman sees a drunk man searching for something under a streetlight and asks what the drunk has lost. He says he lost his keys ...
California
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
Protect Patients By Repealing the Medical Device Tax
You don’t make health care more affordable by increasing its cost. Yet that is precisely what the currently suspended medical device tax threatens unless Congress permanently repeals it. Although permanent repeal failed in the last Congress, Senators Pat Toomey (R-PA) and Amy Klobuchar (D-MN) have introduced the Protect Medical Innovation Act, ...
Gutting patents will stall medicine progress
Congress could soon vote on legislation that would gut America’s intellectual property laws. The bill isn’t just bad news for big pharmaceutical companies that hold lucrative patents. It’s terrible news for patients — medical research spending would dry up without strong patent protections. Americans could lose out on cures for ...
Three Blind Men And The Health Care Industry
Today’s hearing in front of the Senate Finance Committee will, unfortunately, be another wasted opportunity. Surely, Senators will make grandiose speeches and be shocked at the cost of drugs. They will also continue to support the very policies that are causing the problems the hearing is supposed to address. A February 25th editorial ...
Wayne Winegarden Discusses 15% Solution on Lars Larson Show
Listen to Dr. Wayne Winegarden, PRI Senior Fellow in Business and Economics as he joins Lars Larson to discuss his latest report detailing how we reach the “15 Percent Solution”, or the optimal level of federal spending to maximize economic growth and cut the national debt. The interview begins at ...
Facing $22 Trillion National Debt, New PRI Report Shows How “15 Percent Solution” Can Cut Debt, Grow Economy
On the heels of the news that the national debt has surpassed $22 trillion, the Pacific Research Institute today recommended reforms to bring spending under control, reduce the national debt and maximize economic growth in the latest report in its Beyond the New Normal series. “Just last week, as we learned ...
Public Pension Funds’ Sole Responsibility Is To Secure The Retirement Of Public Sector Workers
State and local public pension funds are trillions of dollars in debt. Without fully accounting for the risks, state public pension funds have $1.4 trillion in unfunded liabilities (e.g. debt) according to the Pew Center’s latest estimates. Even more troubling, this debt is still growing. The sole priority of a public pension ...
Fostering Transparency In The Pharmaceutical Market
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation worse because they fail to ...
Medicare price controls would harm patients and workers
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug spending may decline, the ...
Medical Economic Studies Should Come with a Warning Label
The old joke about the drunk and the policeman is apropos for far too many pharmaceutical studies. Typically, the joke goes something like the following: A policeman sees a drunk man searching for something under a streetlight and asks what the drunk has lost. He says he lost his keys ...
Governor Newsom’s troubling first act on medications
In one of his first acts, Governor Newsom signed an executive order that will change how medicines are purchased in California. With visions of big-box store discounts dancing in his head, Governor Newsom has established a bulk program that will now purchase drugs for the state’s Medicaid program (Medi-Cal). The ...
